Resolve Biosciences

Resolve Biosciences is a German biotechnology company founded in 2019, specializing in precision spatial biology and single-cell analysis.

The company is headquartered in Monheim am Rhein, Germany, with an additional facility in San Jose, California. Its flagship product, the Molecular CartographyTM platform, offers high-resolution, multiplexed technology for single-molecule detection at subcellular resolution, preserving sample tissue integrity. The Molecular CartographyTM platform enables researchers to gain full spatial context at the subcellular level, making it suitable for detecting rare transcripts and signals. The platform features a fully automated workflow and is designed to expand its capabilities to include DNA, protein, and metabolomic analysis in the future. Resolve Biosciences serves scientists in oncology, neuroscience, and infectious disease, providing commercial services through a laboratory and offering solutions via subscription or direct service agreements. The company collaborates with ZEISS to enhance its technology, emphasizing its commitment to advancing molecular analysis in life sciences.